CAMP Q3 2020 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$126M

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$84M-10.4% YoY

Gross Profit

$31M36.9% margin

Operating Income

-$6M-7.5% margin

Net Income

-$9M-11.3% margin

EPS (Diluted)

$-0.28

QoQ Revenue Growth

+4.1%

Cash Flow

Operating Cash Flow

$8M

Free Cash Flow

$5M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$482M

Total Liabilities

$363M

Stockholders' Equity

$119M

Cash & Equivalents

$107M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$84M	$93M	-10.4%
Gross Profit	$31M	$38M	-18.2%
Operating Income	-$6M	-$5M	-35.8%
Net Income	-$9M	-$7M	-28.6%

Revenue Segments

Product

$51M61%

Application Subscriptions And Other Services

$33M39%

Geographic Segments

UNITED STATES

$59M71%

E M E A

$16M19%

South America

$6M7%

Asia Pacific

$2M2%

All Other

$2M2%